Effects of Lemon Verbena Extract Supplementation in Sub-ADHD Children
- Conditions
- Behavior, ChildCognitive Change
- Interventions
- Dietary Supplement: PlaceboDietary Supplement: Lemon verbena
- Registration Number
- NCT05476549
- Lead Sponsor
- Northumbria University
- Brief Summary
The aim of this study is to investigate the effects of 15 mg/kg lemon verbena, in comparison to placebo, on the attention deficit hyperactivity disorder (ADHD) type behaviour and cognitive function of children who do not have a diagnosis of ADHD, but who exhibit high scores (highest tertile) on ADHD behaviour parameters. Multiple aspects of mood will also be assessed.
The proposed randomised, double-blind, placebo-controlled, parallel groups design methodology will assess the psychological effects of 15 mg/kg lemon verbena extract and a matched placebo prior to and after 4 and 8 weeks of supplementation. The trial will utilise the COMPASS cognitive assessment system (Northumbria University) and a range of mood measures during laboratory testing visits.
Parents and children will also take part in a concomitant smartphone study, comprising the collection of the parent's assessment of the child's behaviour/cognitive function and the child's self-report of the same, plus their mood. These assessments will take place on Days -1, 14, 28, 42 and 56.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 140
- Are in good health as reported by themselves and their parent/guardian
- Are aged 8 to 17 years at the time of giving assent and parents giving consent
- Have a sex and age-related BMI less than the 98th centile according to the local NHS guidelines
- Are rated by their parents as having a high score (T score of ≥60) on both the Connors 3 subscales of Inattention and Hyperactivity/Impulsivity.
- Have no current diagnosis of ADHD
- Have no relevant food intolerances/ sensitivities/ allergies
- Are not currently using any illicit, herbal or recreational drugs including alcohol and nicotine products
- Are not currently taking prescription medications
- Have not taken dietary supplements e.g. Vitamins, omega 3 fish oils etc. in the last 4 weeks
- Do not have a diagnosed neurological condition, or learning/behavioural or neurodevelopmental differences (e.g. dyslexia, autism)
- Do not suffer from visual (including colour blindness) impairment that cannot be corrected with glasses or lenses (that may impact task performance in the opinion of the PI).
- Do not have any pre-existing diagnosed medical condition/illness which will impact taking part in the study
- Consume less than 250 mg/day of caffeine.
- Can complete all of the study assessments at the training visit
- Are not currently participating in other clinical or nutrition intervention studies, or have in the past 4 weeks
- Are compliant with regards to treatment consumption
- Have not taken antibiotics within the past 4 weeks
- Do not have any health condition that would prevent fulfilment of the study requirements (this includes non-diagnosed conditions for which no medication may be taken)
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Placebo Placebo - Lemon verbena Lemon verbena -
- Primary Outcome Measures
Name Time Method Change in depression-dejection from baseline to 8 weeks Baseline to 8 weeks Profile of mood states questionnaire
Change in systolic blood pressure from baseline to 8 weeks Baseline to 8 weeks Systolic blood pressure (mmHg)
Change in diastolic blood pressure from baseline to 8 weeks Baseline to 8 weeks Diastolic blood pressure (mmHg)
Change in heart rate during the performance of cognitive tasks from baseline to 8 weeks Baseline to 8 weeks Beats per minute
Change in confusion-bewilderment from baseline to 8 weeks Baseline to 8 weeks Profile of mood states questionnaire
Change in body temperature from baseline to 8 weeks Baseline to 8 weeks Degrees Celsius
Change in RMSSD during the performance of cognitive tasks from baseline to 8 weeks Baseline to 8 weeks Root mean square of successive differences between normal heartbeats (RMSSD)
Change in Conners 3 score from baseline to 8 weeks, parent rating Baseline to 8 weeks Change in heart rate variability index during the performance of cognitive tasks from baseline to 8 weeks Baseline to 8 weeks Heart rate variability index
Change in subjective mood from baseline to 8 weeks, alertness Baseline to 8 weeks Visual analogue scale composite score
Change in Conners 3 score from baseline to 8 weeks, child rating Baseline to 8 weeks Change in anger-hostility from baseline to 8 weeks Baseline to 8 weeks Profile of mood states questionnaire
Change in subjective perceived stress from baseline to 8 weeks Baseline to 8 weeks Perceived stress scale (PSS) total score
Change in reaction time of performance on arrow flankers task from baseline to 8 weeks Baseline to 8 weeks Cognitive task score, reaction time in milliseconds
Change in reaction time of performance on rapid visual information processing task from baseline to 8 weeks Baseline to 8 weeks Cognitive task score, reaction time in milliseconds
Change in total mood disturbance from baseline to 8 weeks Baseline to 8 weeks Profile of mood states questionnaire
Change in tension-anxiety from baseline to 8 weeks Baseline to 8 weeks Profile of mood states questionnaire
Change in vigour-activity from baseline to 8 weeks Baseline to 8 weeks Profile of mood states questionnaire
Change in fatigue-inertia from baseline to 8 weeks Baseline to 8 weeks Profile of mood states questionnaire
Change in stress index during the performance of cognitive tasks from baseline to 8 weeks Baseline to 8 weeks The stress index is a measure of the ratio between the parasympathetic and sympathetic tone. intervals exceeds 50 milliseconds.
Change in subjective mood from baseline to 8 weeks, stress Baseline to 8 weeks Visual analogue scale composite score
Change in accuracy of performance from baseline to 8 weeks Baseline to 8 weeks Cognitive task composite score, %
Change in accuracy of performance on arrow flankers task from baseline to 8 weeks Baseline to 8 weeks Cognitive task score, %
Change in accuracy of performance on Corsi blocks task from baseline to 8 weeks Baseline to 8 weeks Cognitive task score, %
Change in accuracy of performance on rapid visual information processing task from baseline to 8 weeks Baseline to 8 weeks Cognitive task score, %
Change in reaction time of performance on Stroop task from baseline to 8 weeks Baseline to 8 weeks Cognitive task score, reaction time in milliseconds
Change in pNN50 during the performance of cognitive tasks from baseline to 8 weeks Baseline to 8 weeks pNN50 is the mean number of times per hour in which the change in consecutive normal sinus (NN) intervals exceeds 50 milliseconds.
Change in subjective anxiety from baseline to 8 weeks Baseline to 8 weeks State-trait anxiety inventory (STAI) total score
Change in subjective mood from baseline to 8 weeks, tranquility Baseline to 8 weeks Visual analogue scale composite score
Change in accuracy of performance on Stroop task from baseline to 8 weeks Baseline to 8 weeks Cognitive task score, %
Change in reaction time of performance on numeric working memory task from baseline to 8 weeks Baseline to 8 weeks Cognitive task score, reaction time in milliseconds
Change in completion time of peg and ball task from baseline to 8 weeks Baseline to 8 weeks Cognitive task score, time in milliseconds
Change in speed of performance from baseline to 8 weeks Baseline to 8 weeks Cognitive task composite score, milliseconds
Change in accuracy of performance on numeric working memory task from baseline to 8 weeks Baseline to 8 weeks Cognitive task score, %
Change in accuracy of performance on peg and ball task from baseline to 8 weeks Baseline to 8 weeks Cognitive task score, number of errors
Change in false alarms on rapid visual information processing task from baseline to 8 weeks Baseline to 8 weeks Cognitive task score, number of false alarms
Change in thinking time of peg and ball task from baseline to 8 weeks Baseline to 8 weeks Cognitive task score, time in milliseconds
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Brain, Performance, Nutrition Research Centre, Northumbria University
🇬🇧Newcastle upon Tyne, Tyne & Wear, United Kingdom